AG
Congress trade
Rep. Andrew Garbarino (R-NY) bought $1K-$15K of Oramed Pharmaceuticals Inc. (ORMP) stock
Andrew Garbarino, U.S. Representative (R-NY), disclosed a purchase of Oramed Pharmaceuticals Inc. (ORMP) stock worth $1K-$15K in a STOCK Act filing on May 24, 2021.
The trade happened on Apr 23, 2021, 31 days before it was made public.
ORMP has moved -51.6% since the trade date, from $9.78 to $4.73 (Sep 25, 2026 close).
- Traded
- Apr 23, 2021
- Disclosed
- May 24, 2021
- Filing delay
- 31 days
- Price since
- -51.6%
- Source
- STOCK Act disclosure
Other trades in this disclosure (3)
More ORMP insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.